title: The possible involvement of tissue type plasminogen activator in luteolysis of rhesus monkey.
abstract: Changes of plasminogen activators (PA) during different stages of development of the corpus luteum, and their possible physiological role in luteolysis were studied in rhesus monkeys. It was demonstrated for the first time that monkey corpus luteal cells not only produce PA, but that the function of the corpus luteum is also closely related to the activity of this enzyme system. Generally, the life span for a corpus luteum in monkey is approximately 14-16 days, its demise beginning thereafter. In the present study, we found that urokinase in the corpus luteum is higher on day 5 and day 10 after human chorionic gonadotrophin injection, while the tissue type (t) PA is mainly produced on day 13 when luteolysis may take place. Progesterone production remained high on day 5 and day 10 and decreased dramatically from day 13, indicating the important role of tPA but not urokinase (u) PA in suppressing luteal function. When purified tPA (but not uPA) monoclonal antibody was added to luteal cell culture to neutralize endogenously produced tPA activity, progesterone production in the cells was increased significantly. Interestingly, prolactin alone was capable of increasing PA production by luteal cells; prolactin together with luteinizing hormone, however, had a synergistic luteotrophic effect.
authors.affiliation: State Key Laboratory of Reproductive Biology, Chinese Academy of Sciences, Beijing, PRC.
authors.forename: Q
authors.initials: Q
authors.lastname: Feng
authors.forename: K
authors.initials: K
authors.lastname: Liu
authors.forename: Z Y
authors.initials: ZY
authors.lastname: Hu
authors.forename: R J
authors.initials: RJ
authors.lastname: Zou
authors.forename: S C
authors.initials: SC
authors.lastname: Yang
authors.forename: Y X
authors.initials: YX
authors.lastname: Liu
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal; D002478:Cells, Cultured; D006063:Chorionic Gonadotropin / Q000494:pharmacology*; D003338:Corpus Luteum / Q000187:drug effects / Q000201:enzymology*; D004357:Drug Synergism; D005260:Female; D006064:Gonadotropins, Equine / Q000494:pharmacology*; D007986:Luteinizing Hormone / Q000494:pharmacology; D008253:Macaca mulatta; D011374:Progesterone / Q000096:biosynthesis; D011388:Prolactin / Q000494:pharmacology; D010959:Tissue Plasminogen Activator / Q000378:metabolism / Q000502:physiology*
chemical_list: D000911:Antibodies, Monoclonal; D006063:Chorionic Gonadotropin; D006064:Gonadotropins, Equine; D011374:Progesterone; D011388:Prolactin; D007986:Luteinizing Hormone; D010959:Tissue Plasminogen Activator